ESCRS - Descemet’s membrane endothelial keratoplasty (1) ;
ESCRS - Descemet’s membrane endothelial keratoplasty (1) ;

Descemet’s membrane endothelial keratoplasty

Descemet’s membrane endothelial keratoplasty
Colin Kerr
Colin Kerr
Published: Wednesday, July 6, 2016
moria-image-1GRAFT PREPARATION Moria has announced an extension in its portfolio for Descemet’s membrane endothelial keratoplasty (DMEK) graft preparation. “In addition to Muraine Punch introduced in 2013 to allow the reverse technique by Prof Muraine (Rouen, France), Moria now releases new Single-Use Donor Vacuum Guarded Punches to safely assist corneal surgeons and/or eye bank practitioners in the preparation of purely endothelial DMEK graft following the SCUBA (“no touch”) technique: the Guarded DMEK Punch (SKU 17207Dxxx),” said a company spokesman. “Its 350-micron guarded blade is designed to make a non-penetrating trephination of the Descemet’s membrane all around 360° without any hinge, so delamination becomes an easy process,” he added. www.moria-surgical.com REVENUE INCREASE Carl Zeiss Meditec AG has announced that it has increased its revenue by 8.6 per cent in the first six months of the fiscal year, to €540.8 million. “The encouraging development of business confirms our strategy. We optimise the clinical benefit of our products without losing sight of the economic aspects of our customers,” said Dr Ludwin Monz, president and CEO of Carl Zeiss Meditec AG. www.zeiss.com/med CE MARK OASIS® Medical has obtained a CE Mark opening the doors to the international market for their SOFT SHIELD® Collagen Corneal Shields, which allow for ocular healing to take place by providing a protective barrier over the surface of the eye. “As the shield gradually degrades, a thin layer of collagen is released which helps lubricate the eye,” said a company spokeswoman. “SOFT SHIELD® Collagen Corneal Shields are clear, pliable, thin film of highly purified bovine collagen that has been lightly crosslinked to provide the desired degradation time on the eye,” added the spokeswoman. www.oasismedical.com
Latest Articles
From Lab to Life: Corneal Repair Goes Cellular

Long-awaited cellular therapies for corneal endothelial disease enter the clinic.

Read more...

Balancing Innovation and Safety

Ensuring access to advanced cell therapies amid regulatory overhaul.

Read more...

With Eyes on Its Future, ESCRS Celebrates Its Past

Winter Meeting offers opportunities to experiment with new concepts and formats.

Read more...

Best of ESCRS Winter Meeting 2024

Read more...

Following the New Generation

EDOF IOLs an option for eyes with mild comorbidities, showing potential in mini-monovision strategies.

Read more...

Refocus on Multifocals

Trifocal IOLs continue to improve as consensus grows regarding indications and contraindications.

Read more...

Common Myths in Presbyopia Correction

Patient education key to satisfaction with refractive IOLs.

Read more...

Reversible Multifocality

Two-lens combination offers low-risk spectacle independence for cataract patients and presbyopes.

Read more...

Managing a Cataract Surgery Refractive Miss

Weighing the pros and cons of options for intraocular intervention.

Read more...

Unleashing OCT’s Full Potential

Performance of newest tool for corneal evaluation meets or beats older standard technologies.

Read more...

;